Antipsychotics · Second-Generation (Atypical)

Aripiprazole

Brand: Abilify, Abilify MyCite, Abilify Maintena

Second-generation (atypical) antipsychotic: dopamine partial agonist

9 cards

Want adaptive tracking?

Create a free account and every review is tracked with spaced repetition. Cards you struggle with come back sooner, and your weak areas surface automatically.

Create free account →

Card Topics

core (2)risk (3)dosing (1)interaction (1)trap (2)

All Cards

1.Aripiprazole: unique mechanism that distinguishes it from all other antipsychotics.

2.Most common movement-related side effect of aripiprazole. How do you distinguish it from anxiety?

3.Aripiprazole dosing: MDD augmentation vs schizophrenia.

4.Aripiprazole CYP metabolism and dose adjustments.

5.Is aripiprazole FDA-approved for bipolar depression as monotherapy?

6.Does aripiprazole raise or lower prolactin?

7.Rare but serious behavioral side effect of aripiprazole requiring patient counseling.

8.Aripiprazole LAI formulations and intervals.

9.Patient started on aripiprazole for augmentation develops worsening insomnia and agitation. What's happening?

Want the full clinical reference for this medication?

Read the Aripiprazole reference page →